Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sodium Valproate (333mg) + Valproic Acid (145mg) Tablet
Therapeutic Category
Neurology, Antiepileptic
Dosage Form
Tablet
Packaging Type
Strip Pack
Packaging
10*10
Price
₹99/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Valpotime CR 500 Tablet is a controlled-release formulation containing Sodium Valproate (333mg) and Valproic Acid (145mg), designed for the management of epilepsy and bipolar disorder. This medication works by stabilizing electrical activity in the brain, which helps prevent seizures and mood swings. The controlled-release mechanism ensures a slow and consistent release of the active ingredients over an extended period, improving the effectiveness of the treatment while reducing the likelihood of side effects.
Valpotime CR 500 is specifically formulated for long-term use, providing better seizure control and mood stabilization throughout the day. It is effective for generalized seizures, focal seizures, and mania associated with bipolar disorder, offering a convenient once-daily dosing regimen. The extended-release properties of the tablet allow for steady therapeutic effects, helping patients maintain a more consistent drug level in their system.
This combination is especially beneficial for individuals requiring long-term management, as it ensures a steady release of medication without the need for frequent dosing.
Common side effects include dizziness, nausea, tremors, weight gain, and hair loss. Serious side effects may include liver problems, blood disorders, or pancreatitis.
Used for the treatment of epilepsy (generalized and focal seizures) and bipolar disorder (mania).
Consult a healthcare professional before use if you have liver disease, are pregnant, or are breastfeeding. Regular blood tests are recommended during treatment.
Store in a cool, dry place away from sunlight. Keep out of reach of children.
Composition : Sodium Valproate I.P. 133mg + Valproic Acid I.P. 58mg (C.R.)
Composition : Sodium Valproate 200mg + Valproic Acid 87mg
Composition : Pregabalin (150mg)
Composition : Pregabalin (300mg) Capsule
Composition : Pregabalin I.P. 50mg + Duloxetine 20mg
Composition : Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg
Composition : Pregabalin-75mg + Duloxetine 30mg Caps (Delayed Release)
Composition : Pregabalin (75mg) + Etoricoxib (60mg)
Composition : Pregabalin (75mg) + Nortriptyline (10mg)
Composition : Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg) + Vitamin D3 (2000IU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sodium Valproate + Valproic Acid Tablet is a high-strength antiepileptic and mood stabilizer used in the management of epilepsy (partial and generalized seizures), bipolar disorder, and migraine prophylaxis. It works by increasing GABA activity in the brain, helping control abnormal electrical activity and stabilizing mood. This higher-strength formulation is commonly used in patients requiring stronger seizure control or maintenance therapy, making it important in the neurology and psychiatry segment.
Medical distributors and wholesalers can benefit from steady demand from neurologists, psychiatrists, and general physicians. Neurological disorders require long-term or lifelong treatment, ensuring consistent prescriptions, repeat purchases, and stable revenue generation.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in neurology, psychiatry, and chronic care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high chronic therapy dependence, strong specialist prescriptions, and growing neurological disease burden, making it a stable, high-value, and repeat-prescription pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in neurology and psychiatric formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the neurological and mental health segment.